In vitro studies show that treatment with obese ATM-exosomes led to glucose intolerance and insulin resistance in myocytes, while lean ATM-exosomes treatment improved systemic insulin sensitivity; however, no protein cargoes in ATM-exosomes were reported [61]. The gene discussed is ATM; the disease is Insulin resistance.